TVGN
Tevogen Bio Holdings Inc. NASDAQ Listed Jan 5, 2022$7.48
Mkt Cap $31.1M
52w Low $4.13
4.7% of range
52w High $75.50
50d MA $6.99
200d MA $24.34
P/E (TTM)
-0.8x
EV/EBITDA
-2.2x
P/B
—
Debt/Equity
-0.4x
ROE
319.1%
P/FCF
-4.4x
RSI (14)
—
ATR (14)
—
Beta
-0.30
50d MA
$6.99
200d MA
$24.34
Avg Volume
30.9K
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
15 INDEPENDENCE BOULEVARD, SUITE #210 · WARREN, NJ 07059 · US
Data updated apr 27, 2026 6:08am
· Source: massive.com